‘The UK is leading a two speed Europe’ (McKinsey & Company, Biotech in Europe: Scaling Innovation May 20, 2019).
One of the key findings and contrary to the received wisdom, is that the UK is totally smashing it on all measures as a Biotech hot spot according to research presented at BioEquity Europe in Barcelona by McKinsey & Company looking at where's hot and where's not.
Of the 1,000 European Biotechs established since 2012 the UK is leading by a country mile and represents 35% of all new Biotechs and according to the report and is leading a two speed Europe (with Germany, France and Spain in relative decline).
Medicines have complex storage and transportation needs, and getting medicines to remote locations requires lots of planning, clever engineering and infrastructure. Check out this video from SciShow on YouTube to find out more about how medicines are transported around the world.
Just this week, Public Health England said that every one person who misses a vaccination is "one too many". There have been 795 cases of mumps in the first three months of 2019, compared with 1031 cases in the whole of 2018. Measles is not far behind in terms of making a comeback, but how does the disease get such a grip, and why does it spread so fast? Check out this video from Stat news to find out more about how measles gets a grip - and remember the most effective way to prevent it is by getting vaccinated.
It's been 50 years since a new treatment for Parkinson's has been discovered. Current treatments focus on treating the motor symptoms of Parkinson's, and come with a whole host of often debilitating side effects. This video forms part of a BIA campaign called Celebrating UK Bioscience, and explores a project between BIA Charity of the year 2018, Parkinson's UK, and BIA member Benevolent AI. Harnessing the power of AI, they hope to identify new targets for drugs, and molecules which may have failed in their particular indication of study, but could be repurposed to help fight Parkinson's. Check out this video #WorldParkinsonsAwarenessWeek
The World Health Organisation is today convening its first expert advisory committee on developing global standards for the governance and oversight of human genome editing. The aim of the two-day meeting, in Geneva, is to examine the scientific, ethical, social and legal challenges of gene-editing and create guidelines and standards for it.
The meeting follows a call last week by some 16 leading scientists from 7 countries: USA; China; Canada; France; Germany; Italy and New Zealand for a global moratorium on heritable genome editing.
Maintaining a highly skilled workforce is vital to business; I can’t imagine anyone reading this blog would dispute that. Similarly indisputable is the need for business to keep up with the latest developments in research and technology. Doctoral training partnerships can help your business to achieve both of these goals, by strengthening ties with academia, shedding light on new ways of working, and increasing recruitment of multi-skilled graduates. UKRI-BBSRC believes that partnerships with the users of research are important in shaping our doctoral training programmes through better understanding of industry’s needs, concerns and aspirations. By working with companies, UKRI-BBSRC seeks to train students capable of becoming future leaders in industry.
The in vitro diagnostics (IVD) industry is an incredibly innovative sector and has an important story to tell. As part of a brand-new initiative to raise awareness of the IVD industry in the UK and the vital role it plays in improving outcomes for patients and in overcoming health challenges, BIVDA has produced the first in a series of videos highlighting the value of IVDs. The release of this video follows the launch of BIVDA’s new channel on YouTube.